HydRegen, an Oxford, UK-based biotechnology company enabling sustainable chemical manufacturing, raised £2.6M in funding.
The round was led by Clean Growth Fund.
The company intends to use the funds for the commercial development and deployment of its technologies through the next 18 months, and to expand its team over the next 12 months.
Led by Dr Holly Reeve (CEO) and Dr Sarah Cleary (Chief Scientific Officer), HydRegen is a biotech company pioneering a novel biotechnology that enables sustainable chemical production and the reduction of the environmental impact of chemical manufacturing and pharmaceutical industries by replacing toxic metal catalysts.
In March 2022, the company received £385k in funding from the UK Innovation & Science Seed Fund (UKI2S), alongside private investors.
FinSMEs
26/04/2023